1- Department of Diabetology, University Hospital of Endocrinology, Medical University, Sofia, Bulgaria.

Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid.

Hormones (Athens). 2006 Oct-Dec;5(4):251-8.


2- Department of Human Kinetics, St. Francis Xavier University, Antigonish, Nova Scotia, Canada.

Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration.

Int J Sport Nutr Exerc Metab. 2003 Sep;13(3):294-302.


3- FRCPE, Deutsche Diabetes-Klinik, Deutsches Diabetes-Zentrum, Leibniz-Institut an der Heinrich-Heine-Universität, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany.

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Diabetes Care. 2006 Nov;29(11):2365-70.


4- Leiden/Amsterdam Center for Drug Research, Vrije Universiteit, Department of Pharmacochemistry, The Netherlands.

The pharmacology of the antioxidant lipoic acid.

Gen Pharmacol. 1997 Sep;29(3):315-31.


5- Department of Endocrinology, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei Province, PR China.

The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.

Clin Endocrinol (Oxf). 2008 May;68(5):716-23. Epub 2007 Dec 7.